Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients
Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients OTTAWA, CANADA, January 30,2025 – Genomadix (genomadix.com), a global leader in point of need precision medicine diagnostics, announced today that they have received a medical device licence (MDL) from Health Canada permitting marketing of its “Genomadix CubeTM […]
